Share-based Payment Arrangement, Expense of BIOLASE, INC from 31 Dec 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIOLASE, INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2024.
  • BIOLASE, INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $51,000, a 82% decline year-over-year.
  • BIOLASE, INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $299,000, a 82% decline year-over-year.
  • BIOLASE, INC annual Share-based Payment Arrangement, Expense for 2023 was $1,232,000, a 47% decline from 2022.
  • BIOLASE, INC annual Share-based Payment Arrangement, Expense for 2022 was $2,303,000, a 39% increase from 2021.
  • BIOLASE, INC annual Share-based Payment Arrangement, Expense for 2021 was $1,662,000, a 51% decline from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIOLASE, INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $299,000 $51,000 -$225,000 -82% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $524,000 $46,000 -$130,000 -155% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $654,000 $113,000 -$578,000 -84% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $1,232,000 $181,000 -$432,000 -70% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2024 2023 FY
Q3 2023 $1,664,000 $276,000 -$315,000 -53% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $1,979,000 $84,000 -$806,000 -91% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $2,785,000 $691,000 +$482,000 +231% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $2,303,000 $613,000 +$437,000 +248% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $1,866,000 $591,000 +$399,000 +208% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,467,000 $890,000 +$524,000 +143% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $943,000 $209,000 -$719,000 -77% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $1,662,000 $176,000 -$827,000 -82% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2024 2023 FY
Q3 2021 $2,489,000 $192,000 -$655,000 -77% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $3,144,000 $366,000 -$435,000 -54% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $3,579,000 $928,000 +$209,000 +29% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $3,370,000 $1,003,000 +$235,000 +31% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2023 2022 FY
Q3 2020 $3,135,000 $847,000 +$77,000 +10% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $3,058,000 $801,000 +$354,000 +79% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $2,704,000 $719,000 -$38,000 -5% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $2,742,000 $768,000 -$138,000 -15% 01 Oct 2019 31 Dec 2019 10-K 17 Mar 2022 2021 FY
Q3 2019 $2,880,000 $770,000 +$166,000 +27% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $2,714,000 $447,000 -$110,000 -20% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $2,824,000 $757,000 +$56,000 +8% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $2,768,000 $906,000 +$303,000 +50% 01 Oct 2018 31 Dec 2018 10-K 31 Mar 2021 2020 FY
Q3 2018 $2,465,000 $604,000 +$140,000 +30% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $2,325,000 $557,000 -$204,000 -27% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $2,529,000 $701,000 +$322,000 +85% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $2,207,000 $603,000 +$6,000 +1% 01 Oct 2017 31 Dec 2017 10-K 30 Mar 2020 2019 FY
Q3 2017 $2,201,000 $464,000 -$224,000 -33% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $2,425,000 $761,000 -$185,000 -20% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2
Q1 2017 $2,610,000 $379,000 -$455,000 -55% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $3,065,000 $597,000 -$497,000 -45% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2019 2018 FY
Q3 2016 $3,562,000 $688,000 +$67,000 +11% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017 2017 Q3
Q2 2016 $3,495,000 $946,000 +$11,000 +1.2% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $3,484,000 $834,000 +$134,000 +19% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q4 2015 $3,350,000 $1,094,000 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
Q3 2015 $621,000 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016 2016 Q3
Q2 2015 $935,000 +$659,000 +239% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2016 Q2
Q1 2015 $700,000 +$390,000 +126% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q2 2014 $1,447,000 $276,000 -$104,000 -27% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $1,551,000 $310,000 -$58,000 -16% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015 2015 Q1
Q4 2013 $1,609,000 $370,000 +$50,000 +16% 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
Q3 2013 $1,559,000 $491,000 +$134,000 +38% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $1,425,000 $380,000 +$40,000 +12% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014 2014 Q2
Q1 2013 $1,385,000 $368,000 -$215,000 -37% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 $1,600,000 $320,000 01 Oct 2012 31 Dec 2012 10-K 06 Mar 2015 2014 FY
Q3 2012 $357,000 +$33,000 +10% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $340,000 -$116,000 -25% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013 2013 Q2
Q1 2012 $583,000 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q3 2011 $324,000 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $456,000 01 Apr 2011 30 Jun 2011 10-Q/A 06 Sep 2012 2012 Q2

BIOLASE, INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,232,000 -$1,071,000 -47% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2024 2023 FY
2022 $2,303,000 +$641,000 +39% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $1,662,000 -$1,708,000 -51% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024 2023 FY
2020 $3,370,000 +$628,000 +23% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2023 2022 FY
2019 $2,742,000 -$26,000 -0.94% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2022 2021 FY
2018 $2,768,000 +$561,000 +25% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2021 2020 FY
2017 $2,207,000 -$858,000 -28% 01 Jan 2017 31 Dec 2017 10-K 30 Mar 2020 2019 FY
2016 $3,065,000 -$285,000 -8.5% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2019 2018 FY
2015 $3,350,000 +$2,117,000 +172% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $1,233,000 -$376,000 -23% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $1,609,000 +$9,000 +0.56% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
2012 $1,600,000 +$72,000 +4.7% 01 Jan 2012 31 Dec 2012 10-K 06 Mar 2015 2014 FY
2011 $1,528,000 +$801,000 +110% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
2010 $727,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.